undefined | Better HN

0 pointsmft_2d ago0 comments

...in the US.

I was mostly trying to make the point that the cost of living crisis is global, affecting many countries, and that your US-centric view doesn't scale. Healthcare costs hitting consumers directly isn't global as most countries have totally different systems.

---

That said, your suggestion that the answer to rampant capitalism making healthcare unaffordable is more rampant capitalism (which you call competition) is... interesting.

And I wasn't advocating for Sanders personally or his policies specifically, just using him as an example of a conviction politician who might have had the chutzpah to take on and dismantle the business-lobbying-politics establishment.

0 comments

matthest2d ago

Ah ok sorry missed that you were talking globally instead of just US.

In the US, our problems stem from a lack of "capitalism," or healthy markets, or whatever anyone wants to label it. Bottom line, it's very much a supply side problem.

In housing, for example, NIMBY laws have for decades restricted all kinds of new housing being built. In capitalism, developers would be allowed to build. So we've very much had the opposite of capitalism.

Cities that are waking up to this and allowing new houses to be built are seeing rents fall across the board.

mft_OP1d ago

> In the US, our problems stem from a lack of "capitalism," or healthy markets, or whatever anyone wants to label it. Bottom line, it's very much a supply side problem.

I'd challenge whether for complex topics like healthcare, there truly ever could/would be a market that would deliver the savings you envisage.

When someone is diagnosed with cancer, you'd expect them to do everything in their power to give the best outcome, right? Wrong. Most people just go to their local hospital, and sadly the quality of physicians, surgeons, treatments offered, and overall care varies tremendously. There are various data to suggest that joining a clinical trial may offer improved outcomes (and of course, in extremis, clinical trial participation is the only way to access experimental treatments) and yet a very small percentage of patients ever do. Anecdotal experience suggests that many patients can barely understand the details of their disease and treatments (which are becoming more technical with time).

My point? For reasons that require further exploration, healthcare "customers" typically aren't sufficiently informed, discerning, engaged, or mobile in the way that would be necessary for a genuine competitive market composed of for-profit providers to function effectively to drive down prices and improve outcomes.

j / k navigate · click thread line to collapse